Author Archive: Kristin Viswanathan

Kristin Viswanathan

Kristin is the manager of reimbursement and health policy at the Biotechnology Industry Organization (BIO). Prior to joining BIO in June 2012, she worked on the Institute of Medicine's preparedness and neuroscience portfolios, and was a health policy research associate at the American Enterprise Institute.

Kristin is originally from the Maryland suburbs of Washington, D.C. and received her undergraduate degree in neuroscience from The Johns Hopkins University and a Master of Public Health from Dartmouth College. Confusing to many, she is a loyal fan of the New York Yankees. Kristin spends her free time volunteering with the Junior League of Washington.

Latest Posts

What International Trade Agreements Have to Do with Innovation

Attendees

Innovation is not just the life-blood of the biotech industry, it is the very premise of the BIO International Convention. So what is a panel on international trade doing here? Answering this question is the task panel moderator, Richard Bergstrom, Director General, EFPIA gave to participants in the session TTIP: Can US and the EU Lead the Way in Setting New Global Benchmarks for IP, Regulatory and Market Access Issues; and each provided a piece Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Differences Between Establishing Value for Approval Versus Coverage?

shutterstock_26191726

Yes, but maybe not irreconcilable. Many of the educational sessions on the first day of the 2014 BIO International Convention touched on one essential question: how can safe and effective treatments get to the patients who need them faster? Panelists in the session Irreconcilable Differences? A Balanced Approach to Establishing Value approached this key question through a discussion of how to shorten the time between—and improve the predictability and expectations around—regulatory approval and coverage and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

National Healthcare Innovation Summit Shines Spotlight on the Value Equation

115x76-health

The first of the two-day National Healthcare Innovation Summit began and ended trying to answer one question: What constitutes value? Morning keynote speaker Ian Morrison boiled it down to this equation: Value = (Cost + Quality + Security)/Cost However, afternoon speakers struggled to limit the discussion to these variables, wanting to include many others, such as the ability of a health system to pay for innovation, the need to sustain continued innovation, underlying risk of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,